Project Details
Projekt Print View

Delivery of the HSV-1 genome through the nuclear pore complex

Subject Area Virology
Term from 2010 to 2013
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 186214281
 
Final Report Year 2014

Final Report Abstract

Within the course of the project, we developed an experimental assay enabling a comprehensive investigation of the nuclear envelope and nuclear pores from diverse perspectives. The assay can be used under both physiological and pathophysiological conditions, and its reliability was demonstrated. Applying this assay, we could determine the structural arrangement of the NPC permeability barrier. Moreover, we demonstrated that a dissociation of NPC proteins is essential to force a significant increase of its permeability. We presented a potent chemical, trans-cyclohexane-1 2-diol (TCHD), which leads to controlled and reversible dissociation of the NPC barrier forming NPC proteins from the NPC channel. The finding concerning the NPC barrier may help design novel strategies for non-viral gene therapy. The same experimental assay mentioned above can be used to study in a comprehensive fashion nuclear delivery mechanism of viral genomes as shown exemplarily using HSV-1. Our results indicate an involvement of hydrophobicity for HSV-1 capsid opening. Furthermore, the viral DNA is released as a single thread. The initial stage of DNA release out of the capsid is very likely pressure-driven. We assume that it penetrates the NPC in this conformation. It is compacted by the host intranuclear proteins once it reaches the interior of the nucleus. Our proposed experimental strategy can be easily extended to other viruses. Finally and along the same line as TCHD, the observations made concerning HSV-1 genome delivery through the NPC may help design novel strategies for non-viral gene therapy. The ultimate goal is to develop non-viral nano-particles mimicking HSV-1 capsid and containing therapeutic DNA. The idea behind this reasoning is to develop nano-particles, which target the therapeutic DNA safely and specifically to the NPC for subsequent nuclear delivery.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung